Steris Stock Surges 12%, With A 6-Day Winning Spree
Steris (STE) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 12% return. The company has gained about $2.8 Bil in value over the last 6 days, with its current market capitalization at about $26 Bil. The stock remains 29.4% above its value at the end of 2024. This compares with year-to-date returns of 16.2% for the S&P 500.
Steris’s recent streak was ignited by robust Q2 earnings, with adjusted EPS of $2.47 topping forecasts and revenue surging 10% to $1.5 billion. This impressive beat, coupled with an elevated FY26 outlook of $10.15-$10.30 EPS, fueled investor confidence in its thriving infection prevention and healthcare segments. For quick background: STE provides infection prevention products and services globally, specializing in healthcare cleaning, sterilization equipment, and life sciences consumables like cleaning chemicals and washer disinfectors.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There is a near-equal mix of good and bad in STE stock given its overall Moderate operating performance and financial condition. But keeping in mind its High valuation, we think that the stock is Unattractive. Deep dive with Buy or Sell STE.
Individual stocks can be volatile and shake you out, but strategic allocation and diversification helps you stay invested. Our Boston-based, wealth management partner’s asset allocation approach is designed exactly for that.
Comparing STE Stock Returns With The S&P 500
The following table summarizes the return for STE stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | STE | S&P 500 |
|---|---|---|
| 1D | 0.1% | 1.5% |
| 6D (Current Streak) | 12.0% | -0.1% |
| 1M (21D) | 11.9% | 4.3% |
| 3M (63D) | 8.6% | 6.0% |
| YTD 2025 | 29.4% | 16.2% |
| 2024 | -5.6% | 23.3% |
| 2023 | 20.2% | 24.2% |
| 2022 | -23.4% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 80 S&P constituents with 3 days or more of consecutive gains and 17 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 30 | 9 |
| 4D | 29 | 6 |
| 5D | 14 | 0 |
| 6D | 5 | 2 |
| 7D or more | 2 | 0 |
| Total >=3 D | 80 | 17 |
Key Financials for Steris (STE)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $5.1 Bil | $5.5 Bil |
| Operating Income | $862.2 Mil | $960.8 Mil |
| Net Income | $378.2 Mil | $614.6 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ1 | 2026 FQ2 |
|---|---|---|
| Revenues | $1.4 Bil | $1.5 Bil |
| Operating Income | $247.8 Mil | $268.0 Mil |
| Net Income | $177.4 Mil | $191.9 Mil |
While STE stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.